|Bid||0.1000 x 19973700|
|Ask||0.1050 x 27494300|
|Day's range||0.0930 - 0.1050|
|52-week range||0.0590 - 0.2000|
|Beta (5Y monthly)||0.20|
|PE ratio (TTM)||6.56|
|Earnings date||31 Aug 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||0.70|
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
Sydney, Australia, June 4, 2020 - (ABN Newswire) - Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced that non-executive director Dr Glen Richards has resigned to allow ...
Sydney, Australia, May 18, 2020 - (ABN Newswire) - Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced that it has received notification that Kyocera Corporation (TYO:6971) ...